Zymeworks’ leading-edge ZymeCAD™ protein engineering technology platform has enabled the development of a diverse portfolio of proprietary antibody and antibody alternative products.
Platform Technologies |
|||||||
|---|---|---|---|---|---|---|---|
| Indication | Partnering | Discovery | In vitro | Ex vivo | In vivo | Clinical | |
| Azymetric™ Scaffold | Multiple |  |
|||||
| AlbuCORE™ Scaffold | Multiple | ||||||
| EFECT™ Platform | Oncology, Autoimmune | ||||||
| HL‧Max™ Platform | Multiple | ||||||
Therapeutics Pipeline |
|||||||
| Program 1 | Oncology | ||||||
| Program 2 | Not Disclosed | ||||||